Serum levels of anti-PF4 IgG after AZD1222 (ChAdOx1 nCoV-19) vaccination.

Cohen, Taylor S; Kelly, Elizabeth J; Nylander, Sven; Bansal, Himanshu; Jepson, Brett M; Bhuyan, Prakash; Sobieszczyk, Magdalena E; Falsey, Ann R

Cohen, Taylor S; Kelly, Elizabeth J; Nylander, Sven; Bansal, Himanshu; Jepson, Brett M; Bhuyan, Prakash; Sobieszczyk, Magdalena E; Falsey, Ann R.

Afiliação

Cohen TS; Microbiome Discovery, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, 20878, USA. taylor.cohen@astrazeneca.com.
Kelly EJ; Translational Medicine, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Nylander S; Clinical Development, Vaccines and Immune Therapies, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Bansal H; Biometrics, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Jepson BM; Biometrics, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Bhuyan P; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Sobieszczyk ME; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY, USA.
Falsey AR; University of Rochester Medical Center, Rochester, NY, USA.

Sci Rep ; 12(1): 7961, 2022 05 13.

Article em En | MEDLINE | ID: mdl-35562373

Assuntos

COVID-19; Trombocitopenia; Trombose; ChAdOx1 nCoV-19; Humanos; Imunoglobulina G; Fatores Imunológicos; Fator Plaquetário 4; Trombocitopenia/etiologia; Vacinação

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitopenia / Trombose / COVID-19 Tipo de estudo: Clinical_trials / Etiology_studies Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google